JOANN E MANSON, M.D.
Osteopathic Medicine at Commonwealth Ave, Boston, MA
License number
Massachusetts 47108
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
2
900 Commonwealth Ave E., Boston, MA 02215
14 Washington St, Beverly Farms, MA 01915
14 Washington St, Beverly Farms, MA 01915
Phone
(617) 278-0871
Personal information
See more information about JOANN E MANSON at radaris.comName
Address
Phone
14 Washington St, Beverly, MA 01915
14 Washington St, Beverly, MA 01915
Professional information
Joann E Manson, Boston MA
Specialties:
Internist
Address:
900 Commonwealth Ave, Boston, MA 02215
Education:
Harvard University - Doctor of Philosophy
Harvard University - Master of Public Health
Case Western Reserve University, School of Medicine - Doctor of Medicine
Brigham & Women's Hospital - Fellowship - Research
Boston Medical Center - Fellowship - Endocrinology
Beth Israel Deaconess Medical Center - Residency - Internal Medicine
Harvard University - Master of Public Health
Case Western Reserve University, School of Medicine - Doctor of Medicine
Brigham & Women's Hospital - Fellowship - Research
Boston Medical Center - Fellowship - Endocrinology
Beth Israel Deaconess Medical Center - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Endocrinology and Metabolism (Internal Medicine)
Treatment Of Patients At Elevated Cardiovascular Risk With A Combination Of A Cholesterol-Lowering Agent, An Inhibitor Of The Renin-Angiotensin System, And Aspirin
US Patent:
2003004, Mar 13, 2003
Filed:
Aug 28, 2001
Appl. No.:
09/942084
Inventors:
Matthew Liang - Boston MA, US
JoAnn Manson - Beverly MA, US
JoAnn Manson - Beverly MA, US
International Classification:
A61K031/714, A61K031/525, A61K009/48, A61K009/20
US Classification:
424/465000, 514/251000, 514/052000
Abstract:
Methods and compositions are provided for reducing the risk of cardiovascular events in individuals who are at elevated cardiovascular risk, including individuals who have systemic lupus erythematosus. The methods comprise administering a combination of: a cholesterol-lowering agent, such as an HMG CoA reductase inhibitor; an inhibitor of the renin-angiotensin system, such as an ACE inhibitor; aspirin; and optionally one or more of vitamin B, vitamin B, and folic acid. Pharmaceutical formulations combining all the active agents in unit-dose form for once-daily dosing are provided.
Chief Of Preventive Medicine At Brigham And Women's Hospital
Position:
Chief of Preventive Medicine at Brigham and Women's Hospital
Location:
Greater Boston Area
Industry:
Hospital & Health Care
Work:
Brigham and Women's Hospital
-
Chief of Preventive Medicine
Education:
Harvard University School of Public Health 1984 - 1987
Dr. Joann E Manson, Boston MA - MD (Doctor of Medicine)
Specialties:
Endocrinology, Diabetes & Metabolism, Endocrinology & Metabolism
Address:
133 Brookline Ave, Boston 02215
Certifications:
Diabetes, Metabolism & Endocrinology, 1987, Internal Medicine, 1982
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
133 Brookline Ave, Boston 02215
Beverly Hospital Corporation
85 Herrick Street Ext, Beverly 01915
Brigham and Women's Hospital
75 Francis St, Boston 02115
Beverly Hospital Corporation
85 Herrick Street Ext, Beverly 01915
Brigham and Women's Hospital
75 Francis St, Boston 02115
Education:
Medical School
Case Western Reserve University School of Medicine
Graduated: 1979
New Eng Deaconess/Harvard
New England Deaconess/Harvard Med Sch
Brigham and Womens Hospital
U Hosp
Case Western Reserve University School of Medicine
Graduated: 1979
New Eng Deaconess/Harvard
New England Deaconess/Harvard Med Sch
Brigham and Womens Hospital
U Hosp
Inflammatory Markers As Tools In The Detection And Prevention Of Diabetes Mellitus And As Tools To Aid In The Selection Of Agents To Be Used For The Prevention And Treatment Of Diabetes
US Patent:
8101363, Jan 24, 2012
Filed:
Dec 14, 2001
Appl. No.:
10/017905
Inventors:
Paul M. Ridker - Chestnut Hill MA, US
JoAnn E. Manson - Beverly MA, US
JoAnn E. Manson - Beverly MA, US
Assignee:
The Brigham and Women's Hospital, Inc. - Boston MA
International Classification:
G01N 33/53
US Classification:
435 71
Abstract:
The invention involves methods for characterizing an individual's risk profile of developing future diabetes or complications of diabetes by obtaining a level of an inflammatory marker in the individual. Preferred inflammatory markers according to the present invention include C reactive protein and interleukin-6. The invention also involves methods for evaluating the likelihood that an individual will benefit from treatment with an agent for reducing the risk of future diabetes.
Methods And Compositions For Predicting A Subject's Susceptibility To And Risk Of Developing Type 2 Diabetes
US Patent:
2012015, Jun 21, 2012
Filed:
Nov 16, 2009
Appl. No.:
13/125961
Inventors:
Simin Liu - Calabasas CA, US
Eric L. Ding - Jamaica Plain MA, US
Joann E. Manson - Beverly MA, US
Eric L. Ding - Jamaica Plain MA, US
Joann E. Manson - Beverly MA, US
International Classification:
C12Q 1/68, A61P 3/10, A61K 31/7088, A61K 38/02, G01N 33/566, C12M 1/40
US Classification:
514 69, 436501, 435 611, 4352872, 514 44 R, 422 69
Abstract:
Aspects of the invention include methods of predicting a subject's susceptibility to developing type 2 diabetes. Embodiments of the methods include obtaining a sex hormone-binding globulin (SHBG) level value for the subject, e.g., by detecting a SHBG plasma concentration and/or a SHBG polymorphism phenotype, and predicting the subject's susceptibility to developing type 2 diabetes from the obtained SHBG level value. Also provided are devices and kits that find use in practicing embodiments of the methods. In addition, methods of treating a subject for type 2 diabetes and/or preventing the onset of type 2 diabetes are provided.